| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.014 | 1 |